





















68Outcomes of the single-stent versus kissing-stents
technique in asymmetric complex aortoiliac
bifurcation lesions
Yongsung Suh, MD,a Young-Guk Ko, MD,b Dong-Ho Shin, MD,b Jung-Sun Kim, MD, PhD,b
Byeong-Keuk Kim, MD, PhD,b Donghoon Choi, MD, PhD,b Myeong-Ki Hong, MD, PhD,b and
Yangsoo Jang, MD, PhD,b Goyang-si, Gyeonggi-do and Seoul, Korea
Objective: This study investigated the outcomes of single-stent vs kissing-stents techniques in asymmetric complex
aortoiliac bifurcation (ACAB) lesions.
Methods: We retrospectively investigated 80 consecutive patients (69 males, 66.6 6 8.7 years) treated with a single stent
and 30 patients (26 males, 67.1 6 7.7 years) treated with kissing stents for ACAB between January 2005 and December
2012 from a single-center cohort. A ACAB lesion was deﬁned as a symptomatic unilateral common iliac artery stenosis
(>50%) combined with intermediate stenosis (30%-50%) in the contralateral common iliac artery ostium. The primary end
point was the primary patency of the ACAB.
Results: The baseline clinical characteristics did not differ signiﬁcantly between the single-stent and the kissing-stents
group. Technical success was achieved in all patients. The single-stent group required fewer stents (1.3 6 0.5 vs 2.3 6
0.8; P < .001) and less bilateral femoral access (55% vs 100%; P < .001). Two patients in the single-stent group (3%)
required bailout kissing stents because of plaque shift to the contralateral side. The major complication rates were 8% in
single-stent vs 13% in the kissing-stent group, which was similar (P[ .399). At 3 years, the single-stent and kissing-stents
group had similar rates of primary patency (89% vs 87%; P[ .916) and target lesion revascularization-free survival (93%
vs 87%; P [ .462).
Conclusions: The single-stent technique in ACAB was safe and showed midterm outcomes comparable with those of
kissing stents. Considering the beneﬁts, such as fewer stents, less bilateral femoral access, and the availability of
contralateral access for future intervention, the single-stent technique may be an advantageous treatment option in
ACAB. (J Vasc Surg 2015;62:68-74.)With the rapid evolution of endovascular therapy
devices and experience of practitioners, increasingly com-
plex peripheral artery lesions are becoming candidates for
endovascular treatment. Endovascular intervention is now
the preferred option for treating obstructive atherosclerotic
diseases of the distal aorta and iliac arteries. Recent Euro-
pean guidelines recommend an endovascular-ﬁrst strategy
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://dx.doi.org/10.1016/j.jvs.2015.02.031II type A, B, and C lesions.1 The kissing-stents technique,
ﬁrst described by Kuffer et al,2 has been adopted for endo-
vascular treatment of complex aortoiliac bifurcation lesions
involving the distal aorta and bilateral ostia of common iliac
arteries (CIAs).3 Even asymmetric aortoiliac lesions
involving unilateral CIA ostium have been treated with
kissing stents due to concerns about unfavorable plaque
shifting and embolization to the contralateral iliac artery.3,4
However, the kissing-stents technique requires more
devices, bilateral femoral artery access, and usually results
in a loss of the future contralateral access option for endo-
vascular treatment of distal lesions. Currently, there is no
generally established consensus on how to treat unilateral
aortoiliac bifurcation lesions. Especially, if a unilateral bifur-
cation lesions has an intermediate stenosis in the contralat-
eral CIA ostium, whether the single-stent or kissing-stents
technique is a better stenting strategy remains unknown.
Thus, the purpose of the present study was to compare
the outcomes of the single-stent vs kissing-stents tech-
niques for the treatment of asymmetric complex aortoiliac
bifurcation (ACAB) lesions.
METHODS
The protocol of this study conforms to the ethical guide-
lines of the 1975 Declaration of Helsinki. The Institutional
Review Board approved this study and waived the require-
ment for informed consent due to its retrospective design.
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angiographic ﬁndings of 439 patients who received endo-
vascular treatment with stent implantation for atheroscle-
rotic aortoiliac diseases from January 2005 to December
2013. Of these patients, 110 met the following inclusion
criteria: presence of symptomatic unilateral CIA stenosis
(>50%) and intermediate stenosis (30%-50%) in the
contralateral CIA ostium, according to a catheter-based
angiography, and aortoiliac bifurcation lesions treated
with a single stent or kissing stents. We excluded aor-
toiliac diseases without involvement of the CIA ostium
(lesions >1 cm distal from the bifurcation), aortoiliac
bifurcation lesions with signiﬁcant (>50%) stenosis of the
adjacent aorta, or aortoiliac bifurcation lesions previously
treated with stents.
The study included 110 patients, of which 80 were
treated with a single stent and 30 were treated with kissing
stents. Before the angioplasty procedure, all patients under-
went physical evaluations, a noninvasive hemodynamic
evaluation (including segmental blood pressures, ankle-
brachial index [ABI], and pulse volume recording), and
at least one imaging test (computed tomography [CT],
magnetic resonance angiography, or color duplex ultra-
sound imaging).
Procedure and periprocedural management. Proce-
dures were routinely performed under local anesthesia sup-
ported by intravenous sedatives with cardiopulmonary
monitoring. After puncture, heparin (5000 IU) was admin-
istered intra-arterially. Additional doses of heparin were
added during the procedure, if necessary, to maintain an
activated clotting time >250 seconds.
In general, single stents were implanted using a retro-
grade approach via the ipsilateral common femoral artery
(CFA) or using a crossover approach via the contralateral
CFA, whereas kissing stents were implanted using a bilat-
eral retrograde CFA approach. In cases where the distal
aorta or CIA was totally occluded, additional brachial ar-
tery access was obtained at the operator’s discretion.
Lesions were crossed with 0.018-inch or 0.035-inch
wires. In cases of total occlusion, the intraluminal or inten-
tional subintimal technique was used for passage of wires,
according to the operator’s preference. All lesions with ste-
nosis >50% were predilated using balloons (6-8 mm)
smaller than the reference vessel diameter. Predilated
lesions were routinely treated by implantation of a Palmaz
Genesis (Cordis, Warren, NJ) or Express (Boston Scienti-
ﬁc, Natick, Mass) balloon-expandable stent, or Smart
(Cordis, Miami Lakes, Fla), Zilver (Cook Medical, Bloo-
mington, Ind), Absolute Pro LL (Abbott Vascular, Abbott
Park, Ill), or Hercules (S & G Biotech, Seongnam,
Gyeonggi-do, Korea) self-expandable stents. Self-
expandable stents were usually preferred for long-
segment or tortuous lesions, whereas balloon-expandable
stents were generally used for short-segment lesions of
the CIA. Stent diameters ranged from 7 to 10 mm.
Balloon-expandable stents were chosen to match the vessel
size. Self-expandable stents were 1 mm oversized to the
vessel diameter.In the single-stent technique, a stent was implanted to
cover the ostium of the target CIA with minimal protru-
sion of the stent into the aorta, without obstructing the
entry into the contralateral iliac artery. In the kissing-
stents technique, two stents were implanted, one in each
CIA, protruding into the aorta and making parallel contact.
All self-expandable stents were routinely postdilated to the
reference vessel size. Additional poststent dilation was per-
formed for all stents where residual stenosis was >30%.
All patients received maintenance doses of aspirin
(100 mg) and clopidogrel (75 mg) for at least 5 days before
the procedure or loading doses of aspirin (250 mg) and clo-
pidogrel (300 mg) 1 day before the procedure. After the
procedure, dual-antiplatelet therapy of aspirin (100 mg)
and clopidogrel (75 mg) was maintained for at least
1 month.
Follow-up. Patients were evaluated after discharge in
regular clinical follow-up visits at 3-month intervals for
1 year and then at 6-month intervals thereafter. After the
procedure, noninvasive hemodynamic evaluations were
performed on all patients before discharge from the hos-
pital and thereafter regularly every 6 months or in cases of
symptom deterioration. At least one imaging test (CT
angiography, color duplex ultrasound imaging, or intra-
arterial angiography) was performed at 1 year, or in cases
with a >0.15 decrement in ABI or if symptoms worsened
by one Rutherford category during follow-up.
Deﬁnitions. The index target vessel was a symptom-
atic CIA with ostial stenosis >50% according to a
catheter-based angiography. Technical success was
deﬁned as successful stent implantation at the target vessel
with residual stenosis <30% on postprocedural angiog-
raphy. The primary end point was the primary patency of
both CIAs, deﬁned as (1) the absence of binary restenosis
($50%) measured by CT angiography, invasive angiog-
raphy, or duplex ultrasound imaging, and (2) a decrease in
ABI >0.15 between postprocedure and follow-up. Peak
velocity >180 cm/s or a lesion/adjacent segment velocity
ratio >2.4 by duplex imaging was considered a signiﬁcant
($50%) stenosis.
Secondary end points included survival free of target
lesion revascularization (TLR) and major adverse events
(MAEs). A MAE was deﬁned as a composite of all-cause
death, binary restenosis of the aortoiliac bifurcation, TLR,
or unplanned amputation. Major procedural complications
were deﬁned as all-cause death, complications requiring
intervention, or unplanned amputation #30 days after the
procedure.
Statistical analysis. Continuous variables are
expressed as means 6 standard deviation and categoric
variables as number and percentage. Comparisons of
continuous variables between the single-stent and the
kissing-stents group were performed using the Student
t-test. Categoric variables were compared using a c2 or
Fisher exact test, as appropriate. Comparisons of variables
before and after the procedure were performed using a
paired t-test. Primary and secondary end points were
determined using Kaplan-Meier survival analysis and





(n ¼ 30) P valueb
Age, years 66.6 6 8.7 67.1 6 7.7 .786
Male gender 69 (86) 26 (87) .955
BMI, kg/m2 23.0 6 3.1 23.3 6 2.8 .667
Hypertension 57 (71) 24 (80) .354
Diabetes mellitus 33 (41) 7 (23) .082
Dyslipidemia 61 (77) 25 (83) .484
Current smokers 44 (55) 16 (53) .876
Chronic kidney disease 11 (14) 6 (20) .419
Coronary artery disease 58 (73) 16 (53) .056
Congestive heart failure 12 (15) 4 (13) .825
Symptoms .198
Claudication 71 (89) 29 (97)
Critical limb ischemia 9 (11) 1 (3)
Baseline TBI
Ipsilateralc 0.58 6 0.20 0.58 6 0.18 .928
Contralateral 0.98 6 0.20 0.95 6 0.11 .573
Baseline ABI
Ipsilateralc 0.50 6 0.20 0.51 6 0.18 .745
Contralateral 0.87 6 0.23 0.85 6 0.13 .628
Discharge medication
Aspirin 80 (100) 30 (100) e
Clopidogrel 73 (91) 28 (93) .723
Statin 64 (80) 26 (87) .419
ABI, Ankle-brachial index; BMI, body mass index; TBI, thigh-brachial
index.
aContinuous data are shown as the mean6 standard deviation and categoric
data as number (%).
bA P value <.05 is considered signiﬁcant.
cThe ipsilateral side is deﬁned as the side of the stented vessel in the single-
stent group and the side of the more severely diseased vessel in the kissing-
stents group.





(n ¼ 30) P value
TASC II classiﬁcation .178
Type A/B 53 (66) 23 (77)
Type C/D 27 (34) 7 (23)
Chronic total occlusion 64 (81) 20 (67) .112
Combined lesions
External iliac artery 24 (30) 11 (37) .504
Ipsilateralb 24 (30) 6 (20) .294
Contralateral 8 (10) 8 (27) .027
Femoropopliteal artery 39 (49) 10 (33) .147
Ipsilateralb 30 (38) 6 (20) .081
Contralateral 27 (34) 7 (23) .292
Infrapopliteal artery 33 (41) 10 (33) .449
Ipsilateralb 25 (31) 8 (27) .640
Contralateral 27 (34) 8 (27) .477
Access site
Unilateral femoral artery 36 (45) e <.001
Bilateral femoral artery 44 (55) 30 (100)
Brachial artery 10 (13) 4 (13) .907
Combined treatment
Femoropopliteal artery 25 (31) 2 (7) .008
Ipsilateralb 21 (26) 1 (3) .007
Contralateral 8 (10) 2 (7) .588
Infrapopliteal artery 5 (6) 1 (3) .549
Ipsilateralb 5 (6) 1 (3) .549
Contralateral 1 (1) 0 (0) .538
Implanted stents, No. 1.3 6 0.5 2.3 6 0.8 <.001
Stent type .123
Balloon-expandable 60 (75) 18 (60)
Self-expandable 20 (25) 12 (40)
Ipsilateralb Contralateral
Size of implanted stents
Diameter, mm 8.2 6 0.9 8.9 6 1.8 9.0 6 1.9 .017c
Length, mm 56.0 6 27.8 62.5 6 25.7 63.5 6 24.6 .266c
TASC II, Trans-Atlantic Inter-Society Consensus for the Management of
Peripheral Arterial Disease.
aContinuous variables are shown as the mean 6 standard deviation and
categoric variables as number (%).
bIpsilateral side is deﬁned as the side of the target common iliac artery
(CIA).
cComparison between the single-stent and the kissing-stents group in the
ipsilateral CIA.
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restenosis were evaluated using univariate and multivariate
Cox regression analyses. The stenting strategy and vari-
ables with P values of < .15 in univariate analysis were
entered into the multivariate analysis. Patients initially
treated with a single stent who received bailout kissing
stents were included in the single-stent group in all
comparative analyses. Bailout kissing stenting was consid-
ered a TLR in the outcome analysis. Statistical analyses
were conducted using IBM PASW Statistics 19.0 software
(IBM Corp, Armonk, NY).
RESULTS
Baseline clinical and procedural characteristics. The
enrolled patients were a mean age of 68 6 9 years (range,
37-83 years). There were 100 patients (91%) with intermit-
tent claudication and 10 (9%) with critical limb ischemia.
Baseline clinical characteristics did not differ signiﬁcantly
between the single-stent and the kissing-stents group
(Table I). Lesion and procedural data are summarized in
Table II. The single-stent group required fewer stents than
the kissing-stents group (1.3 6 0.5 vs 2.3 6 0.8;
P < .001). The mean diameter of implanted stents in the
single-stent group was slightly smaller than that in the
kissing-stents group (8.2 6 0.9 vs 8.9 6 1.8 mm;P ¼ .046). The single-stent group required less frequent
bilateral femoral artery puncture than the kissing-stents
group (55% vs 100%; P < .001).
No patients had signiﬁcant stenosis in the contralateral
CIA. However, the kissing-stents group showed more
frequently combined lesions in the contralateral external
iliac artery than the single-stent group (27% vs 10%;
P ¼ .027). There was no difference between the two
groups in the frequency of combined femoropopliteal or
infrapopliteal artery lesions. A total of 29 patients (26%)
required concurrent treatment for ipsilateral or contralat-
eral infrainguinal lesions. More patients in the single-stent
group received combined treatment for femoropopliteal
artery disease than those in the kissing-stents group (31%
vs 7%; P ¼ .008). Other characteristics were similar
between the two groups.





(n ¼ 30) P value
Technical success 80 (100) 30 (100) e
Major complications 6 (8)b 4 (13) .399
Death 2 (3) 0 (0) 1.000
Procedure-related 1 (1)b 0 (0)
Nonprocedural related 1 (1) 0 (0)
Complications requiring
interventions
5 (6) 4 (13) .252
Plaque shift to
contralateral side
2 (3) 0 1.000
Arterial rupture 1 (1) 0 1.000
Stent thrombosis 0 1 (3) .273
Distal embolization 0 3 (10) .019
Ipsilateral 0 1 (3)
Contralateral 0 2 (7)
Pseudoaneurysm 1 (1) 0 1.000
Retroperitoneal bleeding 1 (1) 0 1.000




Ipsilateral 1.01 6 0.17 0.98 6 0.17 .466
Contralateral 1.03 6 0.16 1.06 6 0.13 .466
ABI
Ipsilateral 0.91 6 0.22 0.91 6 0.23 .850
Contralateral 0.94 6 0.20 0.92 6 0.17 .612
ABI, Ankle-brachial index; TBI, thigh-brachial index.
aContinuous variables are shown as the mean 6 standard deviation and
categoric variables as number (%).
bThe cause of death was retroperitoneal bleeding.
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30 days, including complications, are presented in
Table III. Technical success for the target lesion was ach-
ieved in all patients in both groups. Differences in major
procedural complications between the two groups were not
signiﬁcant. One death related to retroperitoneal bleeding
occurred in the single-stent group and one cardiac death
occurred in the kissing-stents group, which was not directly
related to the procedure.
Two patients in the single-stent group underwent
bailout kissing stenting due to unfavorable plaque shifting
to the contralateral side. These events were considered
cases of TLR. Three patients in the kissing-stents group
experienced distal embolization to the contralateral side
that required intervention (two endovascular and one sur-
gical embolectomy). No patients in the single-stent group
developed signiﬁcant distal embolization. Postprocedural
thigh-brachial index and ABI in the ipsilateral limb as
well as in the contralateral limb did not differ between
the two groups. Fig 1 shows a representative case of
single-stent (A-C) and a case of bailout kissing-stents due
to unfavorable plaque shift (D-F).
Midterm outcomes. Patients were monitored for
39.2 6 27.7 months. During this period, 21 MAEs
occurred, including 12 deaths (5 cardiovascular and 7 non-
cardiovascular causes), 1 unexpected minor amputation, 11
cases of restenosis, and 8 clinically driven TLRs after the
procedure. The single-stent group experienced 16 MAEs,
including 10 deaths (5 cardiovascular and 5 non-
cardiovascular causes), 8 cases of restenosis, 5 TLRs, and 1
unplanned minor amputation. The kissing-stents group
had 2 deaths of noncardiovascular causes, 3 cases of
restenosis, and 3 TLRs. Primary patency, TLR-free sur-
vival, and MAE-free survival after treatment of the ACAB
lesions were not signiﬁcantly different between single-stent
and kissing-stents groups (Fig 2). The primary patency
rates were excellent in the single-stent and kissing-stents
groups, at 93% and 97% at 1 year and 89% and 87% at
3 years, respectively (P ¼ .916 by log-rank test). Fig 3
shows the primary patency and the TLR-free survival in
the target and contralateral CIA according to the stenting
strategy. Primary patency rates and TLR-free survival rates
were not signiﬁcantly different between the single-stent
and the kissing-stents group.
During the follow-up period, 10 patients (9%) under-
went endovascular therapy for distal lower limb artery le-
sions. In the single-stent group, angioplasty procedures
were performed in 2 external iliac, 2 femoropopliteal, and
2 tibial artery lesions. Endovascular treatments were per-
formed in one external iliac and two tibial artery lesions
in the kissing-stents group. These two tibial artery lesions
were treated by an antegrade approach. Univariate and
multivariate Cox regression analyses showed no signiﬁcant
independent risk factors for binary restenosis after stenting
in the ACAB (Table IV). Only body mass index showed a
trend toward an association with risk of restenosis in multi-
variate analysis (hazard ratio, 0.79, 95% conﬁdence inter-
val, 0.61-1.03; P ¼ .076).DISCUSSION
Our main ﬁnding was that the single-stent technique
was safe and achieved similar primary patency and TLR-
free survival rates as the kissing-stents technique in the
treatment of ACAB lesions. Although two patients in the
single-stent group required bailout stenting in the contra-
lateral CIA due to unfavorable plaque shift, the incidence
of such a complication was low (3%) and was manageable
by endovascular treatment. The advantages of the single-
stent strategy were the use of fewer stents and a reduced
need for bilateral femoral punctures.
Aortoiliac bifurcation lesions are deﬁned as TASC II
class A to D lesions depending on their extension into
the proximal aorta and distal iliac arteries.5 However,
they are generally regarded as challenging targets to treat
due to their high plaque burdens and the anatomical prox-
imity of the aorta and both CIAs. To avoid potential risks,
such as occlusion or embolization due to plaque shift and
atherosclerotic progression in the contralateral vessel,
Tegtmeyer et al6 ﬁrst proposed bilateral simultaneous
balloon angioplasty for the treatment of aortoiliac bifurca-
tion lesions. However, the kissing balloon alone was
frequently associated with dissections and residual stenosis.
Therefore, the kissing-stents technique with simultaneous
bilateral implantation of stents has been used for the endo-
vascular treatment of the aortoiliac bifurcation. Previous
studies demonstrated high technical success and favorable
Fig 1. Representative patients with asymmetric complex aortoiliac bifurcation (ACAB) lesions. Single-stent technique:
(A) preprocedural angiography; (B) implantation of an Express 8-mm  27-mm balloon-expandable stent (Boston
Scientiﬁc, Natick, Mass); and (C) ﬁnal angiography. A patient with an ACAB lesion treated with bail-out kissing-stents:
(D) preprocedural angiography; (E) implantation of a Palmaz Genesis 8-mm  59-mm stent (Cordis, Miami Lakes,
Fla) at the right common iliac artery (CIA), with resulting plaque shift to the contralateral CIA (arrow); (F) ﬁnal
angiography after additional implantation of a Palmaz Genesis 8-mm  39-mm stent at the left CIA.
Fig 2. Midterm outcomes of the asymmetric complex aortoiliac bifurcation (ACAB) according to stenting technique:
(A) primary patency, (B) target lesion revascularization (TLR)-free survival, and (C) major adverse event (MAE)-free
survival. All standard errors <10%.
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to 92%,4,7-11 whereas other studies reported relatively
poorer outcomes, with patency rates of 45% to 65%.12-15
The inconsistency in immediate and later outcomes among
previous studies may reﬂect heterogeneity in study popula-
tions, lesion characteristics, and procedural techniques.Several studies have also described treatment of aor-
toiliac diseases with unilateral CIA stenosis using the
kissing-stents technique9,10,12; however, these studies
provided no detailed description of the procedural out-
comes in this particular patient subgroup. In a single
study, Mohamed et al13 reported that there was no
Fig 3. Primary patency is shown for (A) the target common iliac artery (CIA) and (B) the contralateral vessel, and
target lesion revascularization (TLR)-free survival is shown for (C) the target CIA and (D) the contralateral vessel
according to the stenting technique. All standard errors <10%.
Table IV. Risk factors of restenosis in the asymmetric complex aortoiliac bifurcation (ACAB)
Factors
Univariate analysis Multivariate analysis
HR (95% CI) P value HR (95% CI) P value
Age 0.93 (0.87-0.99) .023 0.95 (0.89-1.01) .124
Male 1.31 (0.17-10.38) .798 e
BMI 0.83 (0.67-1.04) .102 0.79 (0.61-1.03) .076
Hypertension 0.28 (0.08-1.06) .034 0.42 (0.11-1.52) .186
Diabetes mellitus 0.32 (0.07-1.51) .149 0.33 (0.05-2.18) .246
Dyslipidemia 2.28 (0.29-18.05) .434 e
Current smoking 4.05 (0.87-18.80) .074 4.31 (0.72-25.89) .110
Congestive heart failure 0.82 (0.10-6.45) .846 e
Chronic kidney disease 1.88 (0.50-7.08) .354
Critical limb ischemia 1.41 (0.18-11.26) .745 e
Combined femoropopliteal disease 2.19 (0.64-7.53) .215
TASC II C/D lesion 1.35 (0.39-4.60) .636
Chronic total occlusion 4.13 (0.52-32.77) .179 2.91 (0.30-27.99) .355
Single-stent strategy 0.93 (0.25-3.52) .916 0.79 (0.19-3.24) .740
Stent diameter 0.98 (0.62-1.53) .914
Stent length 1.01 (0.98-1.03) .509
Balloon-expandable stent 1.71 (0.36-8.00) .497
BMI,Bodymass index;CI, conﬁdence interval;HR,hazard ratio;TASCII,Trans-Atlantic Inter-SocietyConsensus for theManagementofPeripheralArterialDisease.
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kissing-stents procedure during a 3-year follow-up. Thus,
there is limited information regarding outcomes with kiss-
ing stents or any other endovascular technique inunilateral aortoiliac bifurcation lesions. To our knowl-
edge, this is the ﬁrst report comparing outcomes between
the kissing-stents and single-stent technique in ACAB
lesions.
JOURNAL OF VASCULAR SURGERY
74 Suh et al July 2015According toour experience, the single-stent technique in
the ACAB led to midterm outcomes and postprocedural
complication rates similar to those of the kissing-stents tech-
nique. In our study, only 3% of the patients treated with a
single-stent required bailout kissing stents and >90% of the
patients treated with a single-stent demonstrated patency in
the contralateral CIA over 3 years. Therefore, the single-
stent technique in patients with ACAB can be considered
safe. However, the single-stent technique appears to be
more cost-effective because it requires fewer stents and bife-
moral access sites comparedwith the kissing-stents technique.
More importantly, the single-stent strategy may be advanta-
geous because it can preserve the crossover route for future
endovascular intervention in distal lower limb arteries,
whereas the kissing stents make the crossover passage of de-
vices difﬁcult.Multilevel disease involving the aortoiliac artery
and femoropopliteal artery are not infrequent, especially in
elderly patients with diabetes.16 In our study, 45% of the pa-
tients had combined femoropopliteal disease and 39% had
below-the-knee lesions. Approximately 25% of the enrolled
patients required concurrent treatment for ipsilateral or
contralateral distal lesions. Furthermore, during the follow-
up period, 9% of the patients underwent endovascular treat-
ment for distal lower limb artery diseases. Two patients from
the kissing-stents group required endovascular treatment for
distal tibial artery lesions during follow-up. Vascular access op-
tions in these patients were limited, and the procedure was
performed by an antegrade approach. Thus, in patients with
ACAB lesions, placement of a stent at the ostium of the
CIAwithminimal protrusion into the aorta,without obstruct-
ing the entry to the contralateral CIA, appears to be a consid-
erable beneﬁt for potential future endovascular interventions.
The major limitation of our study is its retrospective
study design and the relatively small study population. We
cannot rule out selection bias in the triage of bifurcation
lesions for single-stent or kissing-stents strategies. In addi-
tion, we used angiography to assess the stenosis severity of
the bifurcation lesion. We did not consider geometric vari-
ables, plaque quantity, or characteristics of the bifurcation
lesions or detailed technical factors, such as balloon or stent
size or products, in data analyses because of limited existing
data and the small study volume. These factors may have an
effect on the outcomes of the procedure. Large-scale pro-
spective clinical studies are needed to address these issues.
CONCLUSIONS
The single-stent strategy was safe and as effective as the
kissing-stents strategy in the treatment of ACAB lesions.
Considering the beneﬁts of fewer stents, less frequent bife-
moral access, and the availability of crossover access for
future intervention, the single-stent technique may be an
advantageous treatment option in ACAB lesions.
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